While HPV vaccination can still be immunogenic and provide individual benefits for some adults over age 26, its broader population-level effectiveness and cost-effectiveness are debated and generally not recommended for routine use.
The evidence we hold leans evenly split
official record 3x · fact-check 2x · hedged 1x · crowd & reference 1x